Organisation paid for research Program year 2022 Source: CMS Open Payments

Amo

Neither a doctor nor a teaching hospital

Research payments

$1,751,738

19 payments

Through program year 2022, Amo is reported as receiving $1,751,738 in research payments, across 19 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$388,647	3
2021	Research	$326,396	4
2020	Research	$413,318	6
2019	Research	$623,377	6

Breakdown

Who paid Research payments · program years 2019–2022

Novartis Pharmaceuticals Corporation $1,751,738 19 payments

Studies the money was for Research payments · program years 2019–2022

An Open Label Single Arm Multi Center Extension Study Evaluating Long Term Safety Tolerability and Effectiveness of Ofatumumab in Subjects With Relapsing Multiple Sclerosis $664,945 4 payments
A Two Year Double Blind Randomized Multicenter Active Controlled Study to Evaluate the Safety and Efficacy of Fingolimod Administered Orally Once Daily Versus Interferon Beta 1A I M Once Weekly in Pediatric Patients With Relapsing Remitting Multiple Scler $539,607 6 payments
A Randomized Double Blind Placebo Controlled Parallel Group Study to Evaluate the Efficacy of Two Doses of Cnp520 in Participants at Risk for the Onset of Clinical Symptoms of Ad $228,372 2 payments
A Randomized Double Blind Double Dummy Parallel Group Study Comparing the Efficacy and Safety of Ofatumumab Administered Subcutaneously Versus Teriflunomide Administered Orally in Patients With Relapsing Forms of Multiple Sclerosis $183,101 3 payments
A Two Year Double Blind Randomized Multicenter Active Controlled Study to Evaluate the Safety and Efficacy of Fingolimod Administered Orally Once Daily Versus Interferon Beta 1A I M Once Weekly in Pediatric Patients With Relapsing Remitting Multiple Sclerosis $68,641 2 payments
A 12 Month Randomized Rater and Dose Blinded Study to Compare the Efficacy and Safety of Fingolimod Twenty Five Hundredth of A MG and Half of A MG Administered Orally Once Daily With Glatiramer Acetate 20 MG Administered Subcutaneously Once Daily in Patie $67,072 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.